10:59 AM EST, 11/14/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were moving higher late Thursday morning, rising 0.89% to 1,323.86 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Grifols ( GRFS ) and petroleum refiner Equinor ( EQNR ) , which rose 6% and 3.9% respectively. They were followed by lender Banco Bilbao Vizcaya Argentaria ( BBVA ) and biotech firm BioNTech (BNTX), which were up 2.7% and 1.7% respectively.

The decliners from continental Europe were led by biopharmaceutical companies Genfit ( GNFT ) and Cellectis ( CLLS ) , which fell 9.7% and 4% respectively. They were followed by biopharmaceutical company DBV Technologies ( DBVT ) and medical device maker EDAP TMS ( EDAP ) , which dropped 2.9% and 2.1% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and insurance provider Prudential (PUK), which increased 7.1% and 2.5% respectively. They were followed by communications company WPP ( WPP ) and cruise line operator Carnival (CUK), which rose 1.6% and 1.4% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) and biotech firm Trinity Biotech ( TRIB ) , which tumbled 13% and 10% respectively. They were followed by software firm Endava ( DAVA ) and biopharmaceutical company Amarin ( AMRN ) , which lost 4.4% and 3.9% respectively.